Reynders McVeigh Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,005
Closed -$355K 219
2020
Q1
$355K Sell
2,005
-395
-16% -$74.4K 0.04% 144
2019
Q4
$459K Hold
2,400
0.04% 149
2019
Q3
$404K Sell
2,400
-825
-26% -$134K 0.04% 153
2019
Q2
$540K Hold
3,225
0.06% 137
2019
Q1
$472K Buy
3,225
+825
+34% +$120K 0.05% 141
2018
Q4
$321K Buy
+2,400
New +$393K 0.04% 160
2016
Q1
Sell
-661
Closed -$207K 227
2015
Q4
$207K Buy
+661
New +$197K 0.03% 198
2015
Q3
Sell
-675
Closed -$205K 212
2015
Q2
$205K Hold
675
0.03% 196
2015
Q1
$201K Buy
+675
New +$192K 0.03% 172

Other funds holding AGN

Reynders McVeigh Capital Management's AGN Position: Q2 2020 in Review

Reynders McVeigh Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,005 shares — an estimated $355K sold.

Reynders McVeigh Capital Management first reported a position in AGN in Q1 2015 and held it in 9 quarters. The position peaked at $540K in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Reynders McVeigh Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 2,005 Allergan plc shares in Q2 2020, an estimated $355K.
  • Reynders McVeigh Capital Management first reported a position in Allergan plc in Q1 2015 and held it in 9 quarters.
  • Reynders McVeigh Capital Management's Allergan plc position peaked at $540K in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Reynders McVeigh Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.